| Naziv |
Akcije |
| Jadrijević-Mladar Takač, Milena ; Takač, Vedran ; Crnek-Kunstelj, Vesna ; Barbarić, Monika
QSAR Studies in a Series of Protein Tyrosine Kinase Inhibitors // Knjiga sažetaka, 5. Hrvatski kongres farmacije s međunarodnim sudjelovanjem 'Farmaceutska izvrsnost u službi zdravlja'/ Book of Abstracts, 5th Croatian Congress on Pharmacy with International Participation 'Pharmaceutical Excellence Dedicated to Health' / Zorc, Branka (ur.). Samobor: Hrvatsko farmaceutsko društvo, 2015. str. 179-179 |
|
| Crnek-Kunstelj, Vesna ; Jadrijevic-Mladar-Takac, Milena ; Barbaric, Monika ; Takac, Vedran
Morfing into Teratoma: The Inhibition Role of Developmental Signal Molecules Retinoic Acid and Neural Growth Factor // Periodicum biologorum / Vitale, Branko (ur.). 2014. str. 40-40 |
|
| Jadrijević-Mladar Takač, Milena ; Crnek-Kunstelj, Vesna ; Barbarić, Monika ; Takač, Vedran
Retinoic Acid Activity on Mamalian Embryo in Organ Culture and Evaluation of Hazard and Risk in Correlation Studies between Molecular Descriptors and ADMET Parameters in a Series od X-Category Drugs // Abstracts, 5th PSWC, Poster Session Online, Virtual Gallery / Joseph T. DiPiro (ur.). Hag: International Pharmaceutical Federation (FIP), 2014. str. PC-006-PC-006 |
|
| Jadrijević-Mladar Takač, Milena ; Takač, Vedran ; Barbarić, Monika ; Crnek-Kunstelj, Vesna
Correlation studies between ADMET properties, drug-likeness scores and molecular descriptors in a series of protein tyrosine kinase inhibitors // Book of Abstracts, 2nd International Conference Contemporary Developments in Pharmacy / Gashi, Zehadin (ur.). Prizren: Institute for Pharmaceutical Research and Development, 2014. str. 158-159 |
|
| Jadrijevic-Mladar Takac, Milena ; Takac, Vedran ; Barbaric, Monika ; Crnek-Kunstelj, Vesna
Relationships between Molecular Descriptors, Drug-likeness, ADMET Parameters and Biological Activity of Tyrosine Kinase Inhibitors in a Series of Quinoline, Quinazoline, Pyrido- and Pyrimido-pyrimidine Derivatives // Abstracts, Poster Session Online, Virtual Gallery, 5th PSWC / Joseph T. DiPiro (ur.). Den Haag: International Pharmaceutical Federation (FIP), 2014. str. PC-005-PC-005 |
|
| Jadrijević-Mladar Takač, Milena ; Takač, Vedran ; Crnek-Kunstelj, Vesna ; Barbarić, Monika
QSAR studies in a series of protein tyrosine kinase inhibitors // Book of Abstracts, KINASE 2014, 6th Symposium on kinase inhibitor design, Kinase - past, present and beyond / Churchouse, Maggi (ur.). Cambridge: The Royal Society of Chemistry Biological and Medicinal Chemistry Sector, 2014. str. P-8-P-8 |
|
| Jadrijević-Mladar Takač, Milena ; Takač, Vedran ; Crnek-Kunstelj, Vesna
Evaluation of Substituted Ureas Potential Toxicity by Correlation Studies Using Topological Indices, Molecular Descriptors and ADMET Parameters // European journal of pharmaceutical sciences / Brendl, Martin (ur.). 2013. str. 59-60 |
|
| Kardum-Skelin, Ika
Prepoznavanje elemenata sedimenta mokraća u dijagnostici nefro/uroloških bolesnika // Tečaj trajnog usavršavanja medicinskih biokemičara. Hrvatska komora medicinskih biokemičara.
Zagreb, Hrvatska, 01.01.2013-01.01.2013 |
|
| Jadrijević-Mladar Takač, Milena ; Takač, Vedran ; Crnek-Kunstelj, Vesna
Predicting of ADMET Properties and Correlation Studies in a Series of Cyclic and Acyclic Urea Derivatives // Conference Programme and Book of Abstracts '5th World Conference on Drug Absorption, Transport and Delivery (WCDATD): Responding to Challenging Situations' / Lennernas, Hans ; Langguth, Peter (ur.). Stockholm: European Federation for Pharmaceutical Sciences (EUFEPS), 2013. str. 70-70 |
|
| Jadrijevic-Mladar Takač, Milena ; Takač, Vedran ; Barbarić, Monika ; Crnek-Kunstelj, Vesna
CorrelaCorrelation Studies between Computed Molecular Descriptors and Predicted ADMET Parameters in a Series of Pregnancy Category X Drugs // Conference Proceedings of the 2nd Zagreb International Conference on Pharmaceutical Sciences 'Sharing a vision - Towards better and safe medicines' (2nd ZICPS 2013) / Jadrijević-Mladar Takač, Milena ; Klebovich, Imre ; Shah, Vinod P. (ur.). Zagreb: Hrvatsko farmaceutsko društvo, 2013. str. 353-355 |
|
